Pregled bibliografske jedinice broj: 1212821
Prognostic Value of Catestatin in Severe COVID-19: An ICU-Based Study
Prognostic Value of Catestatin in Severe COVID-19: An ICU-Based Study // Journal of Clinical Medicine, 11 (2022), 15; 1-11 doi:10.3390/jcm11154496 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1212821 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Prognostic Value of Catestatin in Severe COVID-19:
An ICU-Based Study
Autori
Kljakovic-Gaspic, Toni ; Tokic, Daria ; Martinovic, Dinko ; Kumric, Marko ; Supe-Domic, Daniela ; Stojanovic Stipic, Sanda ; Delic, Nikola ; Vrdoljak, Josip ; Vilovic, Marino ; Ticinovic Kurir, Tina ; Bozic, Josko
Izvornik
Journal of Clinical Medicine (2077-0383) 11
(2022), 15;
1-11
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
COVID-19 ; GDF-15 ; SARS-CoV-2 ; catestatin ; intensive care unit ; vitamin D.
Sažetak
Catestatin is a pleiotropic peptide with a wide range of immunomodulatory effects. Considering that patients with a severe COVID-19 infection have a major immunological dysregulation, the aim of this study was to evaluate catestatin levels in patients with COVID-19 treated in the intensive care unit (ICU) and to compare them between the fatal and non-fatal outcomes. The study included 152 patients with severe COVID-19, out of which 105 had a non-fatal outcome and 47 had a fatal outcome. Serum catestatin levels were estimated by an enzyme-linked immunosorbent assay in a commercially available diagnostic kit. The results show that catestatin levels were significantly lower in the fatal group compared to the non-fatal group (16.6 ± 7.8 vs. 23.2 ± 9.2 ng/mL ; p < ; 0.001). Furthermore, there was a significant positive correlation between serum catestatin levels and vitamin D levels (r = 0.338 ; p < ; 0.001) while there was also a significant positive correlation between serum catestatin levels and growth differentiation factor-15 (GDF-15) levels (r = -0.345 ; p < ; 0.001). Furthermore, multivariate logistic regression showed that catestatin, GDF-15 and leukocyte count were significant predictors for COVID-19 survival. These findings imply that catestatin could be playing a major immunomodulatory role in the complex pathophysiology of the COVID-19 infection and that serum catestatin could also be a predictor of a poor COVID-19 outcome.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC Split,
Medicinski fakultet, Split,
Sveučilište u Splitu Sveučilišni odjel zdravstvenih studija
Profili:
Marino Vilović
(autor)
Marko Kumrić
(autor)
Joško Božić
(autor)
Tina Tičinović Kurir
(autor)
Daniela Šupe Domić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI